Skip to main content
TipRanks
Go Ultimate75% OFF

MATERNUS-Kliniken AG (MAK) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

MATERNUS-Kliniken AG has a market cap or net worth of EUR 17.09M. The enterprise value is EUR 221.67M.

Market Cap
EUR 17.09M
Enterprise Value
EUR 221.67M

Share Statistics

MATERNUS-Kliniken AG has 20,970,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
20,970,000
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

MATERNUS-Kliniken AG’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -4.75%.

Return on Equity (ROE)
0.17
Return on Assets (ROA)
-0.09
Return on Invested Capital (ROIC)
-4.75%
Return on Capital Employed (ROCE)
-0.11
Revenue Per Employee
83.93K
Profits Per Employee
-9,886.202
Employee Count
1,406
Asset Turnover
0.79
Inventory Turnover
232.84

Valuation Ratios

The current PE Ratio of MATERNUS-Kliniken AG is -1.25. MATERNUS-Kliniken AG’s PEG ratio is -0.15.

PE Ratio
-1.25
PS Ratio
0.14
PB Ratio
-0.21
Price to FCF
1.34
Price to Operating Cash Flow
1.06
PEG Ratio
-0.15

Income Statement

In the last 12 months, MATERNUS-Kliniken AG had revenue of 118.00M and earned -13.90M in profits. Earnings per share was -0.66.

Revenue
118.00M
Gross Profit
23.00M
Operating Income
-6.12M
Pretax Income
-12.76M
Net Income
-13.90M
EBITDA
4.07M
Earnings Per Share (EPS)
-0.66

Cash Flow

In the last 12 months, operating cash flow was 16.11M and capital expenditures -3.32M, giving a free cash flow of 12.79M billion.

Operating Cash Flow
16.11M
Free Cash Flow
12.79M
Free Cash Flow per Share
0.61

Dividends & Yields

MATERNUS-Kliniken AG pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
74.81%
Earnings Yield
-80.14%

Stock Price Statistics

Beta
0.39
52-Week Price Change
-26.58%
50-Day Moving Average
0.89
200-Day Moving Average
0.98
Relative Strength Index (RSI)
42.96
Average Volume (3m)
3,007

Important Dates

MATERNUS-Kliniken AG upcoming earnings date is Apr 23, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 20, 2026
Next Earnings Date
Apr 23, 2027
Ex-Dividend Date
―

Financial Position

MATERNUS-Kliniken AG as a current ratio of 0.21, with Debt / Equity ratio of -227.32%

Current Ratio
0.21
Quick Ratio
0.20
Debt to Market Cap
5.74
Net Debt to EBITDA
44.02
Interest Coverage Ratio
-0.76

Taxes

In the past 12 months, MATERNUS-Kliniken AG has paid 1.09M in taxes.

Income Tax
1.09M
Effective Tax Rate
-0.09

Enterprise Valuation

MATERNUS-Kliniken AG EV to EBITDA ratio is 152.70, with an EV/FCF ratio of 17.01.

EV to Sales
1.82
EV to EBITDA
152.70
EV to Free Cash Flow
17.01
EV to Operating Cash Flow
13.50

Balance Sheet

MATERNUS-Kliniken AG has EUR 5.05M in cash and marketable securities with EUR 205.41M in debt, giving a net cash position of -EUR 200.36M billion.

Cash & Marketable Securities
EUR 5.05M
Total Debt
EUR 205.41M
Net Cash
-EUR 200.36M
Net Cash Per Share
-EUR 9.55
Tangible Book Value Per Share
-EUR 4.49

Margins

Gross margin is 14.25%, with operating margin of -6.19%, and net profit margin of -11.48%.

Gross Margin
14.25%
Operating Margin
-6.19%
Pretax Margin
-11.01%
Net Profit Margin
-11.48%
EBITDA Margin
1.19%
EBIT Margin
-6.19%

Analyst Forecast

The average price target for MATERNUS-Kliniken AG is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
2.73%
EPS Growth Forecast
-1.80%

Scores

Smart Score
4
AI Score
47